iZafe Group Presents at the “Stora Aktiedagarna”

STOCKHOLM, SWEDEN / ACCESSWIRE / November 28, 2023 / iZafe Group (STO:IZAFE-B) (publ.) hereby announces that CEO Anders Segerström will present an investor presentation on Wednesday, November 29th at 4:25 PM at the “Stora Aktiedagarna” in Stockholm.

On Wednesday, November 29th at 4:25 PM, iZafe will present its operations at the “Stora Aktiedagarna” in Stockholm. The address is Birger Jarlsgatan 61 A. The presentation will also be broadcast live in Swedish at https://invitepeople.com/public/events/af87c9f59a/pages/aa3d4312cf and will be available afterwards on the Youtube channel of Aktiespararna as well as on iZafe’s website.

Questions can be sent via SMS to the number +46(0) 79-347 98 45.
For more information: https://invitepeople.com/events/af87c9f59a

Contacts

Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm

E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group

About iZafe Group AB (publ.)

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company’s solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.

The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company’s Certified Adviser. Further information is available at www.izafegroup.com

Attachments

iZafe Group presents at the “Stora Aktiedagarna”

SOURCE: iZafe Group

View source version on accesswire.com:
https://www.accesswire.com/810732/izafe-group-presents-at-the-stora-aktiedagarna

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

2 hours ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

2 hours ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

2 hours ago